IBDEI04Z ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2069,0)
 ;;=V18.19^^21^194^9
 ;;^UTILITY(U,$J,358.3,2069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2069,1,4,0)
 ;;=4^V18.19
 ;;^UTILITY(U,$J,358.3,2069,1,5,0)
 ;;=5^FM HX ENDO/METAB DIS NEC
 ;;^UTILITY(U,$J,358.3,2069,2)
 ;;=^295312
 ;;^UTILITY(U,$J,358.3,2070,0)
 ;;=V18.8^^21^194^10
 ;;^UTILITY(U,$J,358.3,2070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2070,1,4,0)
 ;;=4^V18.8
 ;;^UTILITY(U,$J,358.3,2070,1,5,0)
 ;;=5^FM HX-INFECT/PARASIT DIS
 ;;^UTILITY(U,$J,358.3,2070,2)
 ;;=^295319
 ;;^UTILITY(U,$J,358.3,2071,0)
 ;;=V19.0^^21^195^3
 ;;^UTILITY(U,$J,358.3,2071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2071,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,2071,1,5,0)
 ;;=5^FAMILY HX-BLINDNESS
 ;;^UTILITY(U,$J,358.3,2071,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,2072,0)
 ;;=V19.19^^21^195^8
 ;;^UTILITY(U,$J,358.3,2072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2072,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,2072,1,5,0)
 ;;=5^FAMILY HX-EYE DISORD NEC
 ;;^UTILITY(U,$J,358.3,2072,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,2073,0)
 ;;=V19.2^^21^195^6
 ;;^UTILITY(U,$J,358.3,2073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2073,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,2073,1,5,0)
 ;;=5^FAMILY HX-DEAFNESS
 ;;^UTILITY(U,$J,358.3,2073,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,2074,0)
 ;;=V19.3^^21^195^7
 ;;^UTILITY(U,$J,358.3,2074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2074,1,4,0)
 ;;=4^V19.3
 ;;^UTILITY(U,$J,358.3,2074,1,5,0)
 ;;=5^FAMILY HX-EAR DISORD NEC
 ;;^UTILITY(U,$J,358.3,2074,2)
 ;;=^295323
 ;;^UTILITY(U,$J,358.3,2075,0)
 ;;=V19.4^^21^195^9
 ;;^UTILITY(U,$J,358.3,2075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2075,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,2075,1,5,0)
 ;;=5^FAMILY HX-SKIN CONDITION
 ;;^UTILITY(U,$J,358.3,2075,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,2076,0)
 ;;=V19.5^^21^195^1
 ;;^UTILITY(U,$J,358.3,2076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2076,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,2076,1,5,0)
 ;;=5^FAM HX-CONGEN ANOMALIES
 ;;^UTILITY(U,$J,358.3,2076,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,2077,0)
 ;;=V19.6^^21^195^2
 ;;^UTILITY(U,$J,358.3,2077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2077,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,2077,1,5,0)
 ;;=5^FAMILY HX-ALLERGIC DIS
 ;;^UTILITY(U,$J,358.3,2077,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,2078,0)
 ;;=V19.7^^21^195^5
 ;;^UTILITY(U,$J,358.3,2078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2078,1,4,0)
 ;;=4^V19.7
 ;;^UTILITY(U,$J,358.3,2078,1,5,0)
 ;;=5^FAMILY HX-CONSANGUINITY
 ;;^UTILITY(U,$J,358.3,2078,2)
 ;;=^44746
 ;;^UTILITY(U,$J,358.3,2079,0)
 ;;=V19.8^^21^195^4
 ;;^UTILITY(U,$J,358.3,2079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2079,1,4,0)
 ;;=4^V19.8
 ;;^UTILITY(U,$J,358.3,2079,1,5,0)
 ;;=5^FAMILY HX-CONDITION NEC
 ;;^UTILITY(U,$J,358.3,2079,2)
 ;;=^295327
 ;;^UTILITY(U,$J,358.3,2080,0)
 ;;=V40.0^^21^196^4
 ;;^UTILITY(U,$J,358.3,2080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2080,1,4,0)
 ;;=4^V40.0
 ;;^UTILITY(U,$J,358.3,2080,1,5,0)
 ;;=5^PROBLEMS WITH LEARNING
 ;;^UTILITY(U,$J,358.3,2080,2)
 ;;=^295424
 ;;^UTILITY(U,$J,358.3,2081,0)
 ;;=V40.1^^21^196^3
 ;;^UTILITY(U,$J,358.3,2081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2081,1,4,0)
 ;;=4^V40.1
 ;;^UTILITY(U,$J,358.3,2081,1,5,0)
 ;;=5^PROB WITH COMMUNICATION
 ;;^UTILITY(U,$J,358.3,2081,2)
 ;;=^295425
 ;;^UTILITY(U,$J,358.3,2082,0)
 ;;=V40.2^^21^196^1
 ;;^UTILITY(U,$J,358.3,2082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,2082,1,4,0)
 ;;=4^V40.2
 ;;^UTILITY(U,$J,358.3,2082,1,5,0)
 ;;=5^MENTAL PROBLEMS NEC
 ;;^UTILITY(U,$J,358.3,2082,2)
 ;;=^295426
